INE089A01031
INE089A01031
DR. REDDY S LABORATORIES
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 997.09B EUR | 1.13T EUR | 1.04T EUR | 1.06T EUR |
Enterprise Value | 976.75B EUR | 1.19T EUR | 1.11T EUR | 1.11T EUR |
Valuation Multiples | ||||
Trailing P/E | 30.12x | 34.14x | 24.38x | 26.04x |
Forward P/E | 20.34x | -- | -- | -- |
Price to Sales | 3.01x | 3.41x | 3.11x | 4.06x |
Price to Book | 2.6x | 2.95x | 2.77x | 2.84x |
EV/Revenue | 2.95x | 3.6x | 3.3x | 4.25x |
EV/EBITDA | 17.87x | 18.25x | 14.03x | 16.37x |
Price to FCF (P/FCF) | -- | 122.62x | 57.01x | 78.36x |
EV/FCF | -- | 129.21x | 60.39x | 82x |
FCF Yield | -0.39% | 0.82% | 1.75% | 1.28% |